Abacus Medicine postpones planned IPO
Abacus Medicine decided today, despite strong anchor investor interest, to postpone the planned Initial Public Offering (IPO), due to the currently unfavourable market environment.
We are happy to help, so please get in touch. Below you will find our main offices, but we have people covering all of Europe.
1620 Copenhagen V
Maglódi út 6
Berliner Straße 8
The Leadenhall Building,
122 Leadenhall Street,
London EC3V 4AB
12/14 Rond-Point des Champs-Elysées
Paris 75008, France